Scarica l'app Stockscreener
219.84
6.88%
-16.23
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché PODD Giù?
Forum
Previsione
Insulet Corporation Borsa (PODD) Ultime notizie
Diabetic insulin pods recalled for manufacturing issue - NewsNation
How The Insulet (PODD) Narrative Is Shifting With Omnipod 5 And Rising Competition - Yahoo Finance
Is It Time To Reassess Insulet (PODD) After Recent Share Price Weakness - Yahoo Finance
Insulet Stock To $154? - Trefis
Why Insulet (PODD) Is Down 7.2% After Omnipod 5 Recall Over Insulin Under-Delivery Risk - finance.yahoo.com
Insulet Corporation stock hits 52-week low at 226.14 USD - Investing.com India
Insulet Corporation stock hits 52-week low at 226.14 USD By Investing.com - Investing.com South Africa
Insulet recalls specific Omnipod 5 insulin pump lots after injuries By Investing.com - Investing.com Australia
Securities Fraud Investigation Into Insulet Corporation (PODD) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - Carroll County Mirror-Democrat
Insulet Corporation (PODD) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - WFXG
Insulet recalls some insulin devices in US over leakage risk - Reuters
Insulet Corp. stock underperforms Friday when compared to competitors - MarketWatch
FDA announces recall of insulin delivery pods - Cardiovascular Business
Securities Fraud Investigation Into Insulet Corporation (PODD) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - The AI Journal
Insulet to spend up to $40M on Omnipod 5 pod recall - The Business Journals
Insulet initiates Omnipod 5 recall following 18 AE reports - Yahoo Finance
Insulet falls as Omnipod 5 Pod medical device correction spotlights manufacturing issue - Quiver Quantitative
Insulin devices recalled over leak risk, reports of 'serious adverse events' - LiveNOW from FOX
Insulet reports 18 serious adverse events with recall of Omnipod 5 insulin pumps - MedTech Dive
Insulet (PODD) Faces Stock Dip After Voluntary Device Correction - GuruFocus
Insulet recalling certain defective Omnipod insulin delivery devices - MSN
Insulet Begins Voluntary Medical Device Correction for Certain Omnipod 5 Pods in the U.S. - Medical Product Outsourcing
Insulet Stock Hits 52-Week Low - Benzinga
Insulet recalling Omnipod insulin delivery units (PODD:NASDAQ) - Seeking Alpha
Insulet Corporation (PODD) Announces Voluntary Medical Device Co - GuruFocus
INSULET recalls specific Omnipod 5 pods due to insulin leak risk - StreetInsider
Insulet Corp. stock outperforms competitors despite losses on the day - MarketWatch
Insulet (PODD) Addresses Manufacturing Issue in Omnipod 5 Pods - GuruFocus
Insulet Issues Voluntary Omnipod 5 Device Correction - TipRanks
Insulet recalls specific Omnipod 5 insulin pump lots after injuries - Investing.com
Insulet (NASDAQ: PODD) faces Omnipod 5 pod correction with up to $40M cost - Stock Titan
Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® 5 Pods in the U.S. - Business Wire
Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System - Medical Product Outsourcing
Swiss National Bank Reduces Position in Insulet Corporation $PODD - MarketBeat
Insulet Corporation $PODD Holdings Boosted by Capital Fund Management S.A. - MarketBeat
Insulet (PODD) AID System Shows Promise in Diabetes Management - GuruFocus
Insulet presents study results for fully closed-loop automated insulin delivery system - marketscreener.com
Insulet Reports Positive Results From Automated Insulin Pump Trial - marketscreener.com
Insulet reports positive results for closed-loop diabetes system - StreetInsider
Insulet Corporation Presents Promising Study Results For Fully Closed-Loop Automated Insulin Delivery System For Adults With Type 2 Diabetes - marketscreener.com
Insulet (PODD): Citigroup Adjusts Price Target Amid Buy Rating | - GuruFocus
Magnetar Financial LLC Has $7.12 Million Stock Holdings in Insulet Corporation $PODD - MarketBeat
Citigroup Adjusts Price Target on Insulet to $338 From $345, Maintains Buy Rating - marketscreener.com
Korea Investment CORP Sells 17,419 Shares of Insulet Corporation $PODD - MarketBeat
Insulet to Present EVOLUTION 2 Results on Omnipod® Fully Closed-Loop System for Adults with Type 2 Diabetes at International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) - BioSpace
Insulet Corporation $PODD Shares Sold by Capital Research Global Investors - MarketBeat
Vinva Investment Management Ltd Makes New Investment in Insulet Corporation $PODD - MarketBeat
Avoiding Lag: Real-Time Signals in (PODD) Movement - Stock Traders Daily
Published on: 2026-03-09 05:40:12 - baoquankhu1.vn
Rhenman & Partners Asset Management AB Grows Stock Position in Insulet Corporation $PODD - MarketBeat
Blair William & Co. IL Sells 20,182 Shares of Insulet Corporation $PODD - MarketBeat
Insulet stock: Is the Omnipod maker your next stealth growth play? - AD HOC NEWS
Insulet Corporation (PODD) Finalizes Severance Agreement with Fo - GuruFocus
Fisher Asset Management LLC Has $14.29 Million Stock Holdings in Insulet Corporation $PODD - MarketBeat
Insulet Finalizes Severance Terms for Departing CFO - TipRanks
Former Insulet (NASDAQ: PODD) CFO Ana Chadwick signs severance deal - Stock Titan
Mass. biotech giants added workers in 2025 despite industry-wide layoffs - The Business Journals
Insulet (PODD) SVP Prem Singh reports tax-withholding share transactions - Stock Titan
Insulet (PODD) SVP uses 253 shares to cover RSU tax withholding - Stock Titan
Insulet (PODD) executive records Form 4 tax-withholding share dispositions - Stock Titan
Insulet Corp (NASDAQ: PODD) SVP withholds 605 shares for taxes - Stock Titan
Insulet (PODD) EVP and COO logs tax-withholding share moves in Form 4 - Stock Titan
0.66%
1.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):